Skip to content

Response to Ovulation induction in PCOS patients

Response to Ovulation Induction in women with different Polycystic Ovarian Phenotypes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/03/032381
Enrollment
85
Registered
2021-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

Control Intervention1: Observational study in PCOS Patients: Observational study in PCOS Patients

Sponsors

Manipal Academy of Higher Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Women between 18 and 35 years of age with Polycystic Ovarian syndrome with Infertility.

Exclusion criteria

Exclusion criteria: a) Women with Infertility due to other factors such as bilateral tubal blockage, endometriosis will not be included. b) Women with other systemic disorders like TB, Diabetes, Hypertension, Hypothyroidism or Hyperthyroidism will not be included in the study

Design outcomes

Primary

MeasureTime frame
a) To see Ovulation Induction response in terms of : No response, Normal Response, Hyperresponse. Timepoint: a) To see Ovulation Induction response in terms of : No response, Normal Response, Hyperresponse. b) Baseline investigations will be considered.

Secondary

MeasureTime frame
a) To compare the demographic characteristics and hormonal levels of Women in different phenotypes of PCOS b) To compare the Ovulation Induction drugs given, dosages and addition of drugs and response to them in different phenotypes of PCOS.Timepoint: a)Comparison will be done between different phenotypes of PCOS. b)After giving Ovulation induction on day 10, TVS will be done and baseline investigations will be considered. c)Dosages of drugs given and any addition of drugs, and response to them in different phenotypes will be measured.

Countries

India

Contacts

Public ContactMrudhula Tummala

Manipal Academy of Higher Education

anjali.suneel@manipal.edu9686448802

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026